News | RIVM

Mesh implants intended to treat pelvic organ prolapse

Synthetic mesh are used to treat patients with pelvic organ prolapse.

Summary International Expert Meeting on breast implant-associated lymphoma

On November 19th 2018, RIVM organised an international expert meeting on a rare type of lymphoma that is associated with breast implants.

Risks of potential release of genetically modified mosquitoes evaluated

On Saba, a Dutch Caribbean island, diseases such as dengue, chikungunya and zika can be reduced by the use of genetically modified mosquitoes.

EFSA agrees with RIVM that potential effect of BPA on the immune system requires further attention

RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.

RIVM recommends more stringent EU standards BPA

More stringent European standards for safe exposure of workers and consumers to bisphenol A (BPA) were proposed in 2014 and 2015.

Nanotechnology increasingly used in medical devices

The application of nanotechnology to design and produce medical devices is increasing. RIVM provides an overview of nanotechnology enabled medical devices.

Biobased alternatives to hormone disrupting substance in cash register receipts

Chemicals made from vegetable or animal waste may be an alternative to the use of the substance Bisphenol A (BPA) in thermal paper. Thermal paper is widely used for cash register receipts.

RIVM provides overview of the possible risks of bisphenol A

RIVM has created an overview of the possible risks of Bisphenol A (BPA) for humans and the environment. BPA is a component of many different products and affects the endocrine system.